Patent intelligence · Companies
Company patent strength
Non-educational filers ranked by their patent portfolio. Grant rate and lapsed share expose where high filing volume is not matched by granted patents. Domestic filers lead — toggle to foreign applicants to see who is entering the Indian market.
Free to browse the ranking. Sign into open a filer's full profile — inventors, filing trend and quality index. See how we rank.
Why this page exists — and how to read it
Filing volume and IP quality are different things. This leaderboard ranks non-educational filers by portfolio, but the grant-rate and lapsed sorts are where the judgement lives: they separate companies whose filings survive examination from those accumulating paper.
- Investors
- High grant rate on steady filing usually means a real R&D engine; big volume with a high lapsed share is a red flag worth asking about.
- Founders & operators
- These are the incumbents and potential acquirers in your space — open a filer to see the walls you'd build against.
- Corporate & R&D
- Benchmark competitors' portfolios and grant rates; toggle to foreign to watch who is entering the Indian market.
💬 The grant-rate sort applies a 20-filing floor so tiny portfolios can't top the list.
3,207 foreign filers with 5+ patents · page 17
| # | Filer | Patents↓ | Granted↓ | Lapsed↓ | Pending↓ | Active |
|---|---|---|---|---|---|---|
| 801 | B BRAUN MELSUNGEN | 19 | 526.3% | 1 | 13 | 2022–2026 |
| 802 | BAUSCH STR BEL SE KG | 19 | 00% | 0 | 19 | 2022–2025 |
| 803 | BRIDGESTONE | 19 | 631.6% | 5 | 8 | 2022–2026 |
| 804 | CHANGXIN MEMORY TECHNOLOGIES | 19 | 736.8% | 1 | 11 | 2023–2024 |
| 805 | COMMSCOPE TECHNOLOGIES | 19 | 00% | 7 | 12 | 2022–2025 |
| 806 | DISPELIX | 19 | 00% | 0 | 19 | 2022–2025 |
| 807 | FERTIN PHARMA A S | 19 | 526.3% | 0 | 14 | 2022–2026 |
| 808 | FIRST SOLAR | 19 | 15.3% | 0 | 18 | 2022–2026 |
| 809 | FRAMATOME | 19 | 00% | 1 | 18 | 2022–2025 |
| 810 | GIESECKE DEVRIENT MOBILE SECURITY GERMANY | 19 | 00% | 0 | 19 | 2023–2024 |
| 811 | HI LEX | 19 | 315.8% | 0 | 16 | 2022–2026 |
| 812 | HITACHI CHANNEL SOLUTIONS | 19 | 947.4% | 2 | 8 | 2020–2025 |
| 813 | KYMERA THERAPEUTICS | 19 | 00% | 1 | 18 | 2022–2026 |
| 814 | LONGI GREEN ENERGY TECHNOLOGY | 19 | 842.1% | 1 | 10 | 2022–2025 |
| 815 | LX SEMICON | 19 | 15.3% | 0 | 18 | 2022–2024 |
| 816 | MEDIMMUNE | 19 | 00% | 3 | 16 | 2022–2025 |
| 817 | NAMICS | 19 | 00% | 0 | 19 | 2024–2026 |
| 818 | NEPTUNE MEDICAL | 19 | 00% | 0 | 19 | 2022–2026 |
| 819 | PALL | 19 | 00% | 0 | 19 | 2022–2026 |
| 820 | PULPEX | 19 | 00% | 0 | 19 | 2024–2025 |
| 821 | R HM | 19 | 15.3% | 4 | 14 | 2016–2025 |
| 822 | SANDVIK COROMANT | 19 | 631.6% | 0 | 13 | 2022–2025 |
| 823 | SANECHIPS TECHNOLOGY | 19 | 1052.6% | 0 | 9 | 2021–2025 |
| 824 | SAURER INTELLIGENT TECHNOLOGY | 19 | 00% | 2 | 17 | 2022–2024 |
| 825 | SIGMA ALDRICH | 19 | 00% | 0 | 19 | 2022–2026 |
| 826 | SUMITOMO PHARMA | 19 | 15.3% | 6 | 12 | 2022–2026 |
| 827 | SUN CHEMICAL | 19 | 315.8% | 0 | 16 | 2022–2026 |
| 828 | UNIVATION TECHNOLOGIES | 19 | 421.1% | 0 | 15 | 2022–2025 |
| 829 | VALMET TECHNOLOGIES | 19 | 210.5% | 0 | 17 | 2020–2025 |
| 830 | VIATRIS | 19 | 00% | 0 | 19 | 2022–2024 |
| 831 | WAYNE FUELING SYSTEMS | 19 | 315.8% | 4 | 12 | 2018–2025 |
| 832 | WIGEN BIOMEDICINE TECHNOLOGY SHANGHAI | 19 | 210.5% | 2 | 15 | 2022–2025 |
| 833 | YOKOGAWA ELECTRIC | 19 | 315.8% | 2 | 14 | 2022–2024 |
| 834 | 6SENSE INSIGHTS | 18 | 316.7% | 1 | 14 | 2022–2025 |
| 835 | ALPS ALPINE | 18 | 15.6% | 0 | 17 | 2022–2026 |
| 836 | ARTIENCE | 18 | 211.1% | 1 | 15 | 2022–2025 |
| 837 | BEIGENE | 18 | 00% | 1 | 17 | 2022–2025 |
| 838 | BROSE FAHRZEUGTEILE SE KOMMANDITGESELLSCHAFT W RZBURG | 18 | 00% | 2 | 16 | 2022–2026 |
| 839 | BURCKHARDT COMPRESSION | 18 | 00% | 1 | 17 | 2022–2026 |
| 840 | CHANGZHOU AAC RAYTECH OPTRONICS | 18 | 00% | 0 | 18 | 2024–2025 |
| 841 | CHONG KUN DANG PHARMACEUTICAL | 18 | 950% | 1 | 8 | 2022–2026 |
| 842 | CXMT | 18 | 15.6% | 0 | 17 | 2023–2025 |
| 843 | DICERNA PHARMACEUTICALS | 18 | 00% | 9 | 9 | 2022–2025 |
| 844 | DORMAKABA SCHWEIZ | 18 | 00% | 0 | 18 | 2023–2026 |
| 845 | ECOLAB USA | 18 | 15.6% | 1 | 16 | 2021–2026 |
| 846 | FIDELITY INFORMATION SERVICES | 18 | 00% | 2 | 16 | 2022–2025 |
| 847 | FOSECO INTERNATIONAL | 18 | 00% | 0 | 18 | 2022–2025 |
| 848 | FUTABA INDUSTRIAL | 18 | 211.1% | 0 | 16 | 2022–2025 |
| 849 | GREEN CROSS | 18 | 15.6% | 0 | 17 | 2020–2026 |
| 850 | GRIPPLE | 18 | 00% | 1 | 17 | 2022–2026 |
Educational institutes are excluded — see the institute leaderboard. Attribution is by patent assignee record; a jointly-owned patent is credited to each co-owner, so a co-filed patent counts for every company on it. "Lapsed" = abandoned, withdrawn, deemed-withdrawn or refused; "Pending" = awaiting examination or in prosecution. Want to filter by technology or value category? Browse the filer explorer →
Rankings use patent-registry status (grant rate, examination, claim depth) as a quality proxy — directional, not advice; see methodology. Read the ranking methodology →